Combined immunodeficiency due to mutations in DOCK2, an activator of Rho GTPases such as RAC1 and RAC2, lead to early‐onset invasive bacterial and viral infections, lymphopenia, and various defective T‐cell, B‐cell, and NK‐cell responses. Here, DOCK2 is linked to viral infectious disease.